{
  "id": 5033007,
  "title": "Kenya: Pharmaceutical Manufacturers Warn of Disruptions Over Delayed Vat Exemptions",
  "url": "https://urgent.news/2026/09/02/kenya-pharmaceutical-manufacturers-warn-of-disruptions-over-delayed",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-02T06:41:14.000Z",
  "source": {
    "name": "AllAfrica Health",
    "slug": "allafrica-health",
    "url": "https://allafrica.com/stories/202609020086.html"
  },
  "original_language": "en",
  "account": "Nairobi — Pharmaceutical manufacturers in Kenya are expressing concern over the potential disruptions to the production and supply of medicines and healthcare products due to delays in processing VAT exemptions. The Federation of Kenya Pharmaceutical Manufacturers reports that companies are currently operating at approximately 30 percent capacity while awaiting the full implementation of VAT exemptions under the Finance Act 2026. The law has reclassified inputs, raw materials, and packaging materials used in pharmaceutical production from zero-rated to VAT-exempt. However, manufacturers claim the approval process has become excessively complicated, with exemptions now processed on an individual consignment basis rather than for a list of products. This results in at least 500 containers being imported each month, making it impractical to obtain individual approvals for every shipment. The federation urges the government to simplify the process and ensure that manufacturers can access VAT exemptions without significant administrative delays. The manufacturers warn that such disruptions not only threaten the industry's operations but also jeopardize the availability of healthcare products for Kenyan citizens. AllAfrica reports from numerous news organizations and individuals, but the final responsibility for content accuracy rests with the individual publishers.",
  "summary": "[Capital FM] Nairobi -- Pharmaceutical manufacturers have warned that delays in processing VAT exemptions could disrupt the production and supply of medicines and other healthcare products in Kenya.",
  "key_points": [
    "Pharmaceutical manufacturers in Kenya face disruptions due to delayed VAT exemptions.",
    "Companies operating at 30% capacity while awaiting full VAT exemption implementation.",
    "Approval process complicated, requiring individual approvals for 500 containers monthly."
  ],
  "editors_take": "Delays in processing VAT exemptions threaten to disrupt Kenya's pharmaceutical production and supply, jeopardizing healthcare products for citizens, as manufacturers face impractical approval processes and operate at reduced capacity.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}